Cargando…

Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models

OBJECTIVES: Patients with type 2 diabetes (T2DM) are suggested to have a higher risk of developing pancreatic cancer. We used two models to predict pancreatic cancer risk among patients with T2DM. METHODS: The original data used for this investigation were retrieved from the National Health Insuranc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Meng Hsuen, Sun, Li-Min, Lin, Cheng-Li, Hsieh, Meng-Ju, Hsu, Chung-Y, Kao, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267763/
https://www.ncbi.nlm.nih.gov/pubmed/30568493
http://dx.doi.org/10.2147/CMAR.S180791
_version_ 1783376150098083840
author Hsieh, Meng Hsuen
Sun, Li-Min
Lin, Cheng-Li
Hsieh, Meng-Ju
Hsu, Chung-Y
Kao, Chia-Hung
author_facet Hsieh, Meng Hsuen
Sun, Li-Min
Lin, Cheng-Li
Hsieh, Meng-Ju
Hsu, Chung-Y
Kao, Chia-Hung
author_sort Hsieh, Meng Hsuen
collection PubMed
description OBJECTIVES: Patients with type 2 diabetes (T2DM) are suggested to have a higher risk of developing pancreatic cancer. We used two models to predict pancreatic cancer risk among patients with T2DM. METHODS: The original data used for this investigation were retrieved from the National Health Insurance Research Database of Taiwan. The prediction models included the available possible risk factors for pancreatic cancer. The data were split into training and test sets: 97.5% of the data were used as the training set and 2.5% of the data were used as the test set. Logistic regression (LR) and artificial neural network (ANN) models were implemented using Python (Version 3.7.0). The F(1), precision, and recall were compared between the LR and the ANN models. The areas under the receiver operating characteristic (ROC) curves of the prediction models were also compared. RESULTS: The metrics used in this study indicated that the LR model more accurately predicted pancreatic cancer than the ANN model. For the LR model, the area under the ROC curve in the prediction of pancreatic cancer was 0.727, indicating a good fit. CONCLUSION: Using this LR model, our results suggested that we could appropriately predict pancreatic cancer risk in patients with T2DM in Taiwan.
format Online
Article
Text
id pubmed-6267763
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-62677632018-12-19 Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models Hsieh, Meng Hsuen Sun, Li-Min Lin, Cheng-Li Hsieh, Meng-Ju Hsu, Chung-Y Kao, Chia-Hung Cancer Manag Res Original Research OBJECTIVES: Patients with type 2 diabetes (T2DM) are suggested to have a higher risk of developing pancreatic cancer. We used two models to predict pancreatic cancer risk among patients with T2DM. METHODS: The original data used for this investigation were retrieved from the National Health Insurance Research Database of Taiwan. The prediction models included the available possible risk factors for pancreatic cancer. The data were split into training and test sets: 97.5% of the data were used as the training set and 2.5% of the data were used as the test set. Logistic regression (LR) and artificial neural network (ANN) models were implemented using Python (Version 3.7.0). The F(1), precision, and recall were compared between the LR and the ANN models. The areas under the receiver operating characteristic (ROC) curves of the prediction models were also compared. RESULTS: The metrics used in this study indicated that the LR model more accurately predicted pancreatic cancer than the ANN model. For the LR model, the area under the ROC curve in the prediction of pancreatic cancer was 0.727, indicating a good fit. CONCLUSION: Using this LR model, our results suggested that we could appropriately predict pancreatic cancer risk in patients with T2DM in Taiwan. Dove Medical Press 2018-11-26 /pmc/articles/PMC6267763/ /pubmed/30568493 http://dx.doi.org/10.2147/CMAR.S180791 Text en © 2018 Hsieh et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Hsieh, Meng Hsuen
Sun, Li-Min
Lin, Cheng-Li
Hsieh, Meng-Ju
Hsu, Chung-Y
Kao, Chia-Hung
Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models
title Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models
title_full Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models
title_fullStr Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models
title_full_unstemmed Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models
title_short Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models
title_sort development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267763/
https://www.ncbi.nlm.nih.gov/pubmed/30568493
http://dx.doi.org/10.2147/CMAR.S180791
work_keys_str_mv AT hsiehmenghsuen developmentofapredictionmodelforpancreaticcancerinpatientswithtype2diabetesusinglogisticregressionandartificialneuralnetworkmodels
AT sunlimin developmentofapredictionmodelforpancreaticcancerinpatientswithtype2diabetesusinglogisticregressionandartificialneuralnetworkmodels
AT linchengli developmentofapredictionmodelforpancreaticcancerinpatientswithtype2diabetesusinglogisticregressionandartificialneuralnetworkmodels
AT hsiehmengju developmentofapredictionmodelforpancreaticcancerinpatientswithtype2diabetesusinglogisticregressionandartificialneuralnetworkmodels
AT hsuchungy developmentofapredictionmodelforpancreaticcancerinpatientswithtype2diabetesusinglogisticregressionandartificialneuralnetworkmodels
AT kaochiahung developmentofapredictionmodelforpancreaticcancerinpatientswithtype2diabetesusinglogisticregressionandartificialneuralnetworkmodels